( nausea vomiting hair loss rashinfu...)Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research,Health

Because of the potential risk of fetal harm, pregnant women should not receive Taxotere(R). Women of childbearing potential should avoid becoming pregnant during treatment with Taxotere(R).

    Before receiving Taxotere(R), tell your doctor if

    -- You have any allergies

    -- You are taking any other medicines - including nonprescription (over-

       the-counter) drugs, vitamins, and dietary or herbal supplements


    When taking Taxotere(R), contact your doctor if

    -- You have symptoms of an allergic reaction (warm sensation, tightness in

       your chest, itching/hives, or shortness of breath)

    -- You experience any other side effects

For full prescribing information, including boxed WARNING, call 800-633-1610 or visit http://www.taxotere.com.

About sanofi-aventis

Sanofi-aventis is one of the world leaders in the pharmaceutical industry, ranking number one in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine and vaccines. Sanofi-aventis is listed in Paris and in New York .

Forward Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements reg
'"/>